Altamira Therapeutics Quote - CYTO

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.30

Bid

0.2921

Ask

0.2922

Volume

0.00 Day's Range 0.00

0.30 52 Week Range 3.49

Market Cap

1.02M

Previous Close

0.30

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

14,422

Shares Outstanding

3,401,524

Dividend Yield

PE Ratio

-2.67

Earnings Per Share (EPS)

-1.14

Revenue

158k

Net Profit

-3.87M

Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore TM / SemaPhore TM delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-4... Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore TM / SemaPhore TM delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. In addition, Altamira holds a 49% stake (with additional economic rights) in Altamira Medica AG, its commercial-stage legacy asset BentrioÂ®, an OTC nasal spray for allergic rhinitis. Further, the Company is in the process of partnering / divesting its inner ear legacy assets. Show more

Sector

Med, Dental, Hosp Eq-whsl

Industry

Med, Dental, Hosp Eq-whsl

Website

altamiratherapeutics.com

Headquarters

Basel, Che

Founded

Altamira Therapeutics Ltd is listed in the Med, Dental, Hosp Eq-whsl sector of the NASDAQ with ticker CYTO. The last closing price for Altamira Therapeutics was US$0.30. Over the last year, Altamira Therapeutics shares have traded in a share price range of US$ 0.30 to US$ 3.49.

Altamira Therapeutics currently has 3,401,524 shares outstanding. The market capitalization of Altamira Therapeutics is US$1.02 million. Altamira Therapeutics has a price to earnings ratio (PE ratio) of -2.67.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.3	0.3	0.3	0	0	CS
4	0	0	0.3	0.3	0.3	0	0	CS
12	-0.1158	-27.8499278499	0.4158	0.43	0.3	14422	0.3	CS
26	-0.485	-61.7834394904	0.785	0.8498	0.3	66423	0.48753059	CS
52	-1.6	-84.2105263158	1.9	3.49	0.3	579220	1.78978359	CS
156	-323.34	-99.9073044123	323.64	860	0.3	2173718	53.1396938	CS
260	-239.7	-99.875	240	1548	0.3	1740561	183.46352744	CS

CYTO - Frequently Asked Questions (FAQ)

What is the current Altamira Therapeutics share price?

The current share price of Altamira Therapeutics is US$ 0.30

How many Altamira Therapeutics shares are in issue?

Altamira Therapeutics has 3,401,524 shares in issue

What is the market cap of Altamira Therapeutics?

The market capitalisation of Altamira Therapeutics is USD 1.02M

What is the 1 year trading range for Altamira Therapeutics share price?

Altamira Therapeutics has traded in the range of US$ 0.30 to US$ 3.49 during the past year

What is the PE ratio of Altamira Therapeutics?

The price to earnings ratio of Altamira Therapeutics is -2.67

What is the cash to sales ratio of Altamira Therapeutics?

The cash to sales ratio of Altamira Therapeutics is 65.52

What is the reporting currency for Altamira Therapeutics?

Altamira Therapeutics reports financial results in CHF

What is the latest annual turnover for Altamira Therapeutics?

The latest annual turnover of Altamira Therapeutics is CHF 158k

What is the latest annual profit for Altamira Therapeutics?

The latest annual profit of Altamira Therapeutics is CHF -3.87M

What is the registered address of Altamira Therapeutics?

The registered address for Altamira Therapeutics is DORNACHERSTRASSE 210, BASEL, 4053

What is the Altamira Therapeutics website address?

The website address for Altamira Therapeutics is altamiratherapeutics.com

Which industry sector does Altamira Therapeutics operate in?

Altamira Therapeutics operates in the MED, DENTAL, HOSP EQ-WHSL sector

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 75.4153 (0.00%)	0
AADIAadi Bioscience Inc	US$ 1.98 (0.00%)	0
AACGATA Creativity Global	US$ 0.9899 (0.00%)	0
AACBUArtius II Acquisition Inc	US$ 10.10 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 75.4153 (0.00%)	0
AADIAadi Bioscience Inc	US$ 1.98 (0.00%)	0
AACGATA Creativity Global	US$ 0.9899 (0.00%)	0
AACBUArtius II Acquisition Inc	US$ 10.10 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 75.4153 (0.00%)	0
AADIAadi Bioscience Inc	US$ 1.98 (0.00%)	0
AACGATA Creativity Global	US$ 0.9899 (0.00%)	0
AACBUArtius II Acquisition Inc	US$ 10.10 (0.00%)	0

Symbol

Price

Vol.